ID   CHKA_HUMAN              Reviewed;         457 AA.
AC   P35790; Q8NE29;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   14-APR-2009, sequence version 3.
DT   10-MAY-2017, entry version 156.
DE   RecName: Full=Choline kinase alpha;
DE            Short=CK;
DE            EC=2.7.1.32;
DE   AltName: Full=CHETK-alpha;
DE   AltName: Full=Ethanolamine kinase;
DE            Short=EK;
DE            EC=2.7.1.82;
GN   Name=CHKA; Synonyms=CHK, CKI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1618328; DOI=10.1016/0014-5793(92)80625-Q;
RA   Hosaka K., Tanaka S., Nikawa J., Yamashita S.;
RT   "Cloning of a human choline kinase cDNA by complementation of the
RT   yeast cki mutation.";
RL   FEBS Lett. 304:229-232(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   GLY-220 AND GLN-422.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19915674; DOI=10.1371/journal.pone.0007819;
RA   Gallego-Ortega D., Ramirez de Molina A., Ramos M.A., Valdes-Mora F.,
RA   Barderas M.G., Sarmentero-Estrada J., Lacal J.C.;
RT   "Differential role of human choline kinase alpha and beta enzymes in
RT   lipid metabolism: implications in cancer onset and treatment.";
RL   PLoS ONE 4:E7819-E7819(2009).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 50-439 IN COMPLEX WITH ADP
RP   AND PHOSPHOCHOLINE, SUBUNIT, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17007874; DOI=10.1016/j.jmb.2006.08.084;
RA   Malito E., Sekulic N., Too W.C., Konrad M., Lavie A.;
RT   "Elucidation of human choline kinase crystal structures in complex
RT   with the products ADP or phosphocholine.";
RL   J. Mol. Biol. 364:136-151(2006).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 75-457 IN COMPLEX WITH
RP   HEMICHOLINIUM-3 AND ADP.
RX   PubMed=20299452; DOI=10.1074/jbc.M109.039024;
RA   Hong B.S., Allali-Hassani A., Tempel W., Finerty P.J. Jr.,
RA   Mackenzie F., Dimov S., Vedadi M., Park H.W.;
RT   "Crystal structures of human choline kinase isoforms in complex with
RT   hemicholinium-3: single amino acid near the active site influences
RT   inhibitor sensitivity.";
RL   J. Biol. Chem. 285:16330-16340(2010).
CC   -!- FUNCTION: Has a key role in phospholipid biosynthesis and may
CC       contribute to tumor cell growth. Catalyzes the first step in
CC       phosphatidylcholine biosynthesis. Contributes to
CC       phosphatidylethanolamine biosynthesis. Phosphorylates choline and
CC       ethanolamine. Has higher activity with choline.
CC       {ECO:0000269|PubMed:19915674}.
CC   -!- CATALYTIC ACTIVITY: ATP + choline = ADP + phosphocholine.
CC       {ECO:0000269|PubMed:19915674}.
CC   -!- CATALYTIC ACTIVITY: ATP + ethanolamine = ADP + O-
CC       phosphoethanolamine. {ECO:0000269|PubMed:19915674}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.2 mM for choline {ECO:0000269|PubMed:17007874,
CC         ECO:0000269|PubMed:19915674};
CC         KM=0.4 mM for ATP {ECO:0000269|PubMed:17007874,
CC         ECO:0000269|PubMed:19915674};
CC         KM=12 mM for ethanolamine {ECO:0000269|PubMed:17007874,
CC         ECO:0000269|PubMed:19915674};
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylcholine
CC       biosynthesis; phosphocholine from choline: step 1/1.
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylethanolamine
CC       biosynthesis; phosphatidylethanolamine from ethanolamine: step
CC       1/3.
CC   -!- SUBUNIT: Heterodimer with CHKB (By similarity). Homodimer.
CC       {ECO:0000250, ECO:0000269|PubMed:17007874,
CC       ECO:0000269|PubMed:20299452}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P35790-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P35790-2; Sequence=VSP_009683;
CC   -!- SIMILARITY: Belongs to the choline/ethanolamine kinase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CHKAID44009ch11q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D10704; BAA01547.1; -; mRNA.
DR   EMBL; AP002807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP002992; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036471; AAH36471.1; -; mRNA.
DR   CCDS; CCDS8178.1; -. [P35790-1]
DR   CCDS; CCDS8179.1; -. [P35790-2]
DR   PIR; S23104; S23104.
DR   RefSeq; NP_001268.2; NM_001277.2. [P35790-1]
DR   RefSeq; NP_997634.1; NM_212469.1. [P35790-2]
DR   UniGene; Hs.77221; -.
DR   PDB; 2CKO; X-ray; 2.15 A; A/B=50-457.
DR   PDB; 2CKP; X-ray; 3.10 A; A/B=50-457.
DR   PDB; 2CKQ; X-ray; 2.40 A; A/B=50-457.
DR   PDB; 2I7Q; X-ray; 1.90 A; A=75-457.
DR   PDB; 3F2R; X-ray; 2.35 A; A/B=75-457.
DR   PDB; 3G15; X-ray; 1.70 A; A/B=75-457.
DR   PDB; 3ZM9; X-ray; 1.90 A; A/B=75-457.
DR   PDB; 4BR3; X-ray; 2.20 A; A/B=75-457.
DR   PDB; 4CG8; X-ray; 1.75 A; A=75-457.
DR   PDB; 4CG9; X-ray; 1.83 A; A=75-457.
DR   PDB; 4CGA; X-ray; 1.74 A; A=75-457.
DR   PDB; 4DA5; X-ray; 2.40 A; A/B=1-457.
DR   PDB; 5AFV; X-ray; 2.25 A; A/B=80-457.
DR   PDB; 5EQE; X-ray; 2.40 A; A/B=75-457.
DR   PDB; 5EQP; X-ray; 2.35 A; A/B=75-457.
DR   PDB; 5EQY; X-ray; 2.50 A; A/B=75-457.
DR   PDB; 5FTG; X-ray; 1.45 A; A=80-457.
DR   PDB; 5FUT; X-ray; 1.60 A; A=80-457.
DR   PDBsum; 2CKO; -.
DR   PDBsum; 2CKP; -.
DR   PDBsum; 2CKQ; -.
DR   PDBsum; 2I7Q; -.
DR   PDBsum; 3F2R; -.
DR   PDBsum; 3G15; -.
DR   PDBsum; 3ZM9; -.
DR   PDBsum; 4BR3; -.
DR   PDBsum; 4CG8; -.
DR   PDBsum; 4CG9; -.
DR   PDBsum; 4CGA; -.
DR   PDBsum; 4DA5; -.
DR   PDBsum; 5AFV; -.
DR   PDBsum; 5EQE; -.
DR   PDBsum; 5EQP; -.
DR   PDBsum; 5EQY; -.
DR   PDBsum; 5FTG; -.
DR   PDBsum; 5FUT; -.
DR   ProteinModelPortal; P35790; -.
DR   SMR; P35790; -.
DR   BioGrid; 107543; 5.
DR   IntAct; P35790; 1.
DR   STRING; 9606.ENSP00000265689; -.
DR   BindingDB; P35790; -.
DR   ChEMBL; CHEMBL3117; -.
DR   DrugBank; DB00122; Choline.
DR   iPTMnet; P35790; -.
DR   PhosphoSitePlus; P35790; -.
DR   BioMuta; CHKA; -.
DR   DMDM; 226694197; -.
DR   EPD; P35790; -.
DR   MaxQB; P35790; -.
DR   PaxDb; P35790; -.
DR   PeptideAtlas; P35790; -.
DR   PRIDE; P35790; -.
DR   DNASU; 1119; -.
DR   Ensembl; ENST00000265689; ENSP00000265689; ENSG00000110721. [P35790-1]
DR   Ensembl; ENST00000356135; ENSP00000348454; ENSG00000110721. [P35790-2]
DR   GeneID; 1119; -.
DR   KEGG; hsa:1119; -.
DR   UCSC; uc001onj.4; human. [P35790-1]
DR   CTD; 1119; -.
DR   DisGeNET; 1119; -.
DR   GeneCards; CHKA; -.
DR   H-InvDB; HIX0017419; -.
DR   HGNC; HGNC:1937; CHKA.
DR   HPA; CAB072803; -.
DR   HPA; HPA024153; -.
DR   MIM; 118491; gene.
DR   neXtProt; NX_P35790; -.
DR   OpenTargets; ENSG00000110721; -.
DR   PharmGKB; PA26468; -.
DR   eggNOG; KOG2686; Eukaryota.
DR   eggNOG; COG0510; LUCA.
DR   GeneTree; ENSGT00530000062991; -.
DR   HOGENOM; HOG000041274; -.
DR   HOVERGEN; HBG050943; -.
DR   InParanoid; P35790; -.
DR   KO; K14156; -.
DR   OMA; YMEYAQA; -.
DR   OrthoDB; EOG091G06UK; -.
DR   PhylomeDB; P35790; -.
DR   TreeFam; TF313549; -.
DR   BioCyc; MetaCyc:HS03334-MONOMER; -.
DR   BRENDA; 2.7.1.32; 2681.
DR   Reactome; R-HSA-1483191; Synthesis of PC.
DR   Reactome; R-HSA-1483213; Synthesis of PE.
DR   SABIO-RK; P35790; -.
DR   UniPathway; UPA00558; UER00741.
DR   UniPathway; UPA00753; UER00737.
DR   ChiTaRS; CHKA; human.
DR   EvolutionaryTrace; P35790; -.
DR   GeneWiki; CHKA; -.
DR   GenomeRNAi; 1119; -.
DR   PRO; PR:P35790; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000110721; -.
DR   CleanEx; HS_CHKA; -.
DR   ExpressionAtlas; P35790; baseline and differential.
DR   Genevisible; P35790; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0033265; F:choline binding; IEA:Ensembl.
DR   GO; GO:0004103; F:choline kinase activity; IDA:UniProtKB.
DR   GO; GO:0004104; F:cholinesterase activity; IEA:Ensembl.
DR   GO; GO:0008144; F:drug binding; IDA:UniProtKB.
DR   GO; GO:0004305; F:ethanolamine kinase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0004871; F:signal transducer activity; TAS:ProtInc.
DR   GO; GO:0019695; P:choline metabolic process; IEA:Ensembl.
DR   GO; GO:0006580; P:ethanolamine metabolic process; IEA:Ensembl.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0006869; P:lipid transport; TAS:ProtInc.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006646; P:phosphatidylethanolamine biosynthetic process; IDA:UniProtKB.
DR   GO; GO:1904681; P:response to 3-methylcholanthrene; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; IEA:Ensembl.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   SUPFAM; SSF56112; SSF56112; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Kinase; Lipid biosynthesis; Lipid metabolism;
KW   Nucleotide-binding; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Polymorphism; Reference proteome;
KW   Transferase.
FT   CHAIN         1    457       Choline kinase alpha.
FT                                /FTId=PRO_0000206219.
FT   NP_BIND     117    123       ATP.
FT   NP_BIND     207    213       ATP.
FT   REGION      119    121       Substrate binding.
FT   COMPBIAS     50     85       Pro-rich.
FT   BINDING     146    146       ATP.
FT   BINDING     308    308       ATP. {ECO:0000305}.
FT   BINDING     330    330       ATP.
FT   VAR_SEQ     155    172       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009683.
FT   VARIANT     220    220       S -> G (in dbSNP:rs17853641).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_054863.
FT   VARIANT     422    422       L -> Q (in dbSNP:rs17853642).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_054864.
FT   CONFLICT     49     54       GGQQPP -> APTAA (in Ref. 1; BAA01547).
FT                                {ECO:0000305}.
FT   CONFLICT     87     87       T -> A (in Ref. 1; BAA01547).
FT                                {ECO:0000305}.
FT   CONFLICT    154    154       M -> V (in Ref. 1; BAA01547).
FT                                {ECO:0000305}.
FT   HELIX        85     98       {ECO:0000244|PDB:5FTG}.
FT   HELIX       101    105       {ECO:0000244|PDB:5FTG}.
FT   HELIX       108    110       {ECO:0000244|PDB:5FTG}.
FT   STRAND      112    117       {ECO:0000244|PDB:5FTG}.
FT   STRAND      119    128       {ECO:0000244|PDB:5FTG}.
FT   STRAND      136    138       {ECO:0000244|PDB:5FUT}.
FT   STRAND      141    147       {ECO:0000244|PDB:5FTG}.
FT   HELIX       176    189       {ECO:0000244|PDB:5FTG}.
FT   STRAND      196    200       {ECO:0000244|PDB:5FTG}.
FT   STRAND      203    207       {ECO:0000244|PDB:5FTG}.
FT   STRAND      211    213       {ECO:0000244|PDB:5FTG}.
FT   HELIX       216    220       {ECO:0000244|PDB:5FTG}.
FT   HELIX       222    236       {ECO:0000244|PDB:5FTG}.
FT   HELIX       248    262       {ECO:0000244|PDB:5FTG}.
FT   HELIX       268    278       {ECO:0000244|PDB:5FTG}.
FT   HELIX       282    294       {ECO:0000244|PDB:5FTG}.
FT   STRAND      300    303       {ECO:0000244|PDB:5FTG}.
FT   HELIX       309    311       {ECO:0000244|PDB:5FTG}.
FT   STRAND      312    315       {ECO:0000244|PDB:5FTG}.
FT   HELIX       318    320       {ECO:0000244|PDB:3G15}.
FT   STRAND      322    324       {ECO:0000244|PDB:5FUT}.
FT   STRAND      326    328       {ECO:0000244|PDB:5FTG}.
FT   STRAND      335    338       {ECO:0000244|PDB:5FTG}.
FT   HELIX       339    349       {ECO:0000244|PDB:5FTG}.
FT   STRAND      352    354       {ECO:0000244|PDB:3ZM9}.
FT   HELIX       366    368       {ECO:0000244|PDB:5FTG}.
FT   HELIX       372    386       {ECO:0000244|PDB:5FTG}.
FT   HELIX       388    392       {ECO:0000244|PDB:5FTG}.
FT   HELIX       395    430       {ECO:0000244|PDB:5FTG}.
FT   STRAND      433    435       {ECO:0000244|PDB:3G15}.
FT   HELIX       437    455       {ECO:0000244|PDB:5FTG}.
SQ   SEQUENCE   457 AA;  52249 MW;  65F177ABE1AA3A12 CRC64;
     MKTKFCTGGE AEPSPLGLLL SCGSGSAAPA PGVGQQRDAA SDLESKQLGG QQPPLALPPP
     PPLPLPLPLP QPPPPQPPAD EQPEPRTRRR AYLWCKEFLP GAWRGLREDE FHISVIRGGL
     SNMLFQCSLP DTTATLGDEP RKVLLRLYGA ILQMRSCNKE GSEQAQKENE FQGAEAMVLE
     SVMFAILAER SLGPKLYGIF PQGRLEQFIP SRRLDTEELS LPDISAEIAE KMATFHGMKM
     PFNKEPKWLF GTMEKYLKEV LRIKFTEESR IKKLHKLLSY NLPLELENLR SLLESTPSPV
     VFCHNDCQEG NILLLEGREN SEKQKLMLID FEYSSYNYRG FDIGNHFCEW MYDYSYEKYP
     FFRANIRKYP TKKQQLHFIS SYLPAFQNDF ENLSTEEKSI IKEEMLLEVN RFALASHFLW
     GLWSIVQAKI SSIEFGYMDY AQARFDAYFH QKRKLGV
//
